The effects of different antiembolic agents on the crystallinity of fractured bones during the healing period

dc.contributor.authorTunc, Burcu
dc.contributor.authorAksoy, Emin Emin
dc.contributor.authorUsta, Metin
dc.contributor.authorÜçişik, Ahmet Hikmet
dc.date.accessioned2025-10-29T12:07:46Z
dc.date.issued2009
dc.departmentFakülteler, Mühendislik Fakültesi, Malzeme Bilimi ve Mühendisliği Bölümü
dc.descriptionWorld Congress on Medical Physics and Biomedical Engineering: Image Processing, Biosignal Processing, Modelling and Simulation, Biomechanics -- Munich -- 81642
dc.description.abstractIn order to decrease the potential clinical problems that could be caused by embolism Antiembolic agents are routinely used in orthopaedics& traumatology clinics, especially after arthroplastic operations or in case of having tumor and major trauma in order. This study was designed to evaluate the side effects of different antiembolic agents on the bone fracture healing. After experiments on animals, where "enoxaparin", "fondaparinux" and "heparin" are used as antiembolic agents given after bone fracture, fractured and healed bones are studied by using X-Ray Diffraction technique. To reach this idea, initially, rat which was used as experimental animal was injected by different antiembolic agents. After sacrificing (with the permission of ethical committee) of animal, XRD studies were performed on the bones in Material Laboratories of GYTE (Gebze Yuksek Technology Enstitusu) in order to reveal changes in the crystallinity of the bone samples. © 2021 Elsevier B.V., All rights reserved.
dc.identifier.doi10.1007/978-3-642-03882-2_407
dc.identifier.endpage1537
dc.identifier.isbn9783032043719
dc.identifier.isbn9783642039034
dc.identifier.isbn9783030318659
dc.identifier.isbn9783031422423
dc.identifier.isbn9783642293047
dc.identifier.isbn9783319122618
dc.identifier.isbn9783031901966
dc.identifier.isbn9783642130380
dc.identifier.isbn9783031821226
dc.identifier.isbn9783031469329
dc.identifier.issn1680-0737
dc.identifier.issn1433-9277
dc.identifier.issue4
dc.identifier.scopus2-s2.0-77950143719
dc.identifier.scopusqualityQ4
dc.identifier.startpage1535
dc.identifier.urihttps://doi.org/10.1007/978-3-642-03882-2_407
dc.identifier.urihttps://hdl.handle.net/20.500.14854/14099
dc.identifier.volume25
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherSpringer Verlag
dc.relation.ispartofIFMBE Proceedings
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20251020
dc.subjectBone healing
dc.subjectEnoxaparin
dc.subjectFondaparinux
dc.subjectHeparine
dc.subjectXRD
dc.titleThe effects of different antiembolic agents on the crystallinity of fractured bones during the healing period
dc.typeConference Object

Dosyalar